{"schema_version":"secwatch.filing_event.v1","accession":"0001023024-25-000099","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2025-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.145704+00:00","generated_at":"2026-05-17T05:31:18.789996+00:00","sec_items":["3.02","3.03"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ANI converts all Series A preferred to common; 602,900 shares issued, preferred eliminated","bullets":["On Sep 26, 2025, ANI mandatorily converted 20,000 preferred shares into 482,320 common shares at $41.4662/share.","On Aug 14, 2025, Ampersand converted 5,000 preferred shares into 120,580 common shares at the same price.","All 25,000 preferred shares converted into 602,900 common shares; no preferred shares remain outstanding.","Mandatory conversion triggered because 20-day VWAP exceeded 170% of conversion price ($70.50) after second anniversary."],"urls":{"canonical":"https://secwatch.observer/filing/0001023024-25-000099","json":"https://secwatch.observer/filing/0001023024-25-000099.json","markdown":"https://secwatch.observer/filing/0001023024-25-000099.md","text":"https://secwatch.observer/filing/0001023024-25-000099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000099/0001023024-25-000099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000102302425000099/ani-20250926.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:31:18.789996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}